Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Neuro > AD > Flashcards

AD Flashcards

1
Q

what is dementia ?

A

progressive loss of cognitive and intellectual functions without impairment of perception or consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the causes of dementia?

A

caused by a afriety of disorders including severe infections and toxins but most commonly associated with structural brain disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is dementia characterised by?

A
  • disorientation
  • impaired memory
  • judgement
  • intellect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the range of disease in dementia and that could act as cause?

A
  1. Alzheimers disease
  2. Vascular dementia
  3. mixed - AD + VD
  4. dementia with levy bodies
  5. parkinsons dementia
  6. fronto-temporal dementia (FTD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the macroscopic neuropathological hallmarks of AD?

A
  1. cortex atrophy, hippocampus atrophy by 4-8% a year
  2. deeper and wider sulci
  3. smaller gyri
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which region is not affected in AD?

A
  • cerebellum not affected in AD therefore used as controls in some studies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the microscopic neuropathological hallmarks of AD?

A 
plaque = amyloidpathy, extracellular 
tangles = tauopathy, intracellular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the break staging?

A

neurofibrillary tangles had characteristic distribution pattern in six stages
Stage 1 and 2 – trans entorhinal, clinically silent
Stage 3 and 4 ) – limbic, in developing AD
Stage 5 and 6 – neocortical, fully developed AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is CAA?

A

cerebro amyloid antipathy

  • cerebral hypoperfusion due to accumulation ot tau around affected arteriole
  • demonstrated several years before the onset of clinical AD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are proteinopathies seen in brain disease?

A
  1. Lewy bodies (alpha syncuclein) - PD, LBD
  2. TDP43 inclusions - ALS, FTD
  3. FUS - ALS, FTD
  4. Tau protein - AD, FTD, CBD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the misfolded proteins in AD?

A
  1. beta amyloid
  2. hyperphosphorylated tau
  3. alpha-synuclein
  4. TDP-43
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the three main mutations that were found in early onset Alzheimers (EOAD)?

A
  1. Amyloid precursor protein - APP ~50mutations
  2. Presenilin 1 ~220 mutations
  3. Presenilin 2 ~15 mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

the mutation of the early onset Alzheirmer’s (EAOD) is mainly

  1. Familial AD (FAD)
  2. sporadic AD (SAD)
A
  1. Familial AD (FAD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

on which chromosome is APP gene found?

A

chromosome 21, 18 axons in man and is highly conserved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the structure of APP?

A
  • transmembrane protein with large extracellular domain

- consists of a N and C terminal with alpha, beta and gamma site on the Abeta domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how many isoforms are present in APP and how long is the shortest one?

A

8 isoforms

shortest one - 695AA (highly expressed in brain)

17
Q

APP is not just expressed in brain but is concentrated at synapses also?
A. True
B. False

A

A. True

18
Q

what and how are the two products obtained from APP processing?

A
  1. soluble APPalpha - the proteolytic activity (cutting by proteases) at the alpha site results in soluble APPalpha
  2. soluble abeta - the proteolytic activity at beta and gamma cleavage site results in soluble abeta
19
Q

what is the function of

  1. soluble APPalpha
  2. soluble abeta
A
  1. soluble APPalpha - mediates neuronal growth
  2. soluble abeta (1-40,1-42) - when liberated they stick to each other forming aggregates and plaques which result in neuronal loss
20
Q

where are they most likely to play a role?

  1. abeta1-40
  2. abeta1-42
A
  1. abeta1-40 in CAA (cerebro amyloid angiopathy)

2. abeta1-42 in brain parenchyma

21
Q

which enzyme mediates the proleptic activity at the gamma cleavage site?

A

gamma secretase

22
Q

why do APP mutations cause AD?

A

~50 mutations in ~120 families and almost all dominant

23
Q

what type of proteases are PSEN1 and 2?

A

aspartyl proteases

24
Q

how many components are present in gamma secretase and which is they key one?

A
  • 4 components

- key one = presenilin 1, forms the catalytic of subunit go gamma secretase

25
Q

what are the following features of PSEN1?

  1. chromosome
  2. axons
  3. mutations
A
  1. chromosome 14q
  2. 12 axons
  3. 220 mutations - the most common form in FAD >50% cases
26
Q

what is the role of GWAS?

A

to identify SNPs and other variants in DNA associated with a disease but cannot specify casual genes on their own

27
Q

what is tauopathy composed of and it forms into what?

A

composed of hyperphosprylated tau protein which forms into paired helical filaments

28
Q

what is the structure of tau?

  1. on which chromosome
  2. axons
  3. isoforms
A
  • tau protein located on chromosome 17q of MAPT gene in humans
  • 11 axons and 6 isoforms
29
Q

what does the hyperphosphorylation of tau result in?

A
  1. self assembly to PHFs/SF (paired helical filament/ straight filament)
  2. sequestration of normal tau, MAP1 and MAP2 and consequent disruption of MTs
30
Q

what is the number of moles of phosphate per mole of tau in healthy and AD individuals?

A

healthy individual - 2-3 moles of phosphate per mole of tau

AD - this rises to to 3-4 fold

31
Q

how does tau protein mediate self assembly?

A

some tau protein in AD brain becomes truncated which seems to promote self assembly

32
Q

where is tau mislocalised in AD?

A

usually found in axons but in AD they translocate to different places like spine

33
Q

what is the prionic spread of tau?

A

it is the idea that tau is transmitted b/w neurons, thus supporting the ‘neuronal connectivity’ account of pathology spreading

34
Q

how do we know that tau has prionic spread?

A

inoculation of tau aggregates isolated from the AD patients brain/ tau transgenic mice/ other tauopathies into human tau transgenic mice or WT type mice induces time-dependent spread of tau pathology from the inoculation site to synoptically connected brain regions

35
Q

how to stop AD?

A
  1. stop APP from being turned into abtea fragments/ stop the abeta formation from APP
  2. destroy the abeta fragments
  3. stop the abtea from assembling into toxic forms (stop the plaque formation)
  4. understand how abeta causes trouble (neuronal toxicity) and then intervene
  5. stop tau pathology (+ kinase block - to prevent the phosphorylation)
  6. stop the prionic spread of tau
36
Q

how does one show new drugs work?

A
  1. memory tests - ADAS-Cog, MMSE

2. brain imaging - MRI, PET

37
Q

how are the animal models of dementia created?

A
  • genetically modify mice to produce dementia like pathology in the brain
  • by introducing mutations that produce inherited human dementia into mice
  • e.g. APP knock in mice for AD
38
Q

what are the ways to measure mouse memory?

A
  1. Morris water maze test
  2. PDAPP mouse
  3. imaging single mouse neurons working in the intact brain
  4. testing drugs
39
Q

what is the difference between beta and gamma secretase?

A
  1. beta secretase enzyme is BACE1 and gamma secretase consists of PSEN, PEN2
  2. beta secretase cleaves the APP protein at N terminal (~1) and gamma secretase cleaves at C terminal (~40)

Neuro (8 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions